John P. Schmid's Net Worth
$385 Thousand
Who is John P. Schmid?
John P. Schmid does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include XERIS PHARMACEUTICALS INC, Trius Therapeutics Inc, Auspex Pharmaceuticals, Inc., Design Therapeutics, Inc., Poseida Therapeutics, Inc., ANAPTYSBIO, INC, Xeris Biopharma Holdings, Inc., Neos Therapeutics, Inc., and Helix Acquisition Corp.
SEC CIK
John P. Schmid's CIK is 0001478916
Past Insider Trading and Trends
2021 was John P. Schmid's most active year for acquiring shares with 10 total transactions. John P. Schmid's most active month to acquire stocks was the month of May. 2011 was John P. Schmid's most active year for disposing of shares, totalling 18 transactions. John P. Schmid's most active month to dispose stocks was the month of February. 2023 saw John P. Schmid paying a total of $9,815.00 for 125,500 shares, this is the most they've acquired in one year. In 2013 John P. Schmid cashed out on 444,497 shares for a total of $2,971,336.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
XERIS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.66K |
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trius Therapeutics Inc No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -107.64K |
—
|
—
|
0
|
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| -1.64% | -1.80K |
$6.00 | -$10,800.00 | 107.64K |
Scheduled
|
Jun 22
| ||
Form 4
| +4.79% | 5K |
$1.29 | $6,450.00 | 109.44K |
Mar 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| -0.48% | -500.00 |
$5.04 | -$2,520.00 | 104.44K |
Scheduled
|
Mar 1
| ||
Form 4
| -0.47% | -500.00 |
$5.63 | -$2,815.00 | 104.94K |
Scheduled
|
Feb 2
| ||
Form 4
| -0.66% | -700.00 |
$7.28 | -$5,096.00 | 105.44K |
Scheduled
|
Jan 3
| ||
Form 4
| -0.66% | -700.00 |
$7.50 | -$5,250.00 | 106.14K |
Scheduled
|
Dec 1
| ||
Form 4
| -0.09% | -100.00 |
$7.00 | -$700.00 | 106.84K |
Scheduled
|
Nov 7
| ||
Form 4
| -0.56% | -600.00 |
$6.75 | -$4,050.00 | 106.94K |
Scheduled
|
Nov 1
| ||
Form 4
| -0.19% | -200.00 |
$7.00 | -$1,400.00 | 107.54K |
Scheduled
|
Oct 26
| ||
Form 4
| -0.55% | -600.00 |
$6.33 | -$3,798.00 | 107.74K |
Scheduled
|
Oct 3
| ||
Form 4
| -0.55% | -600.00 |
$6.60 | -$3,960.00 | 108.34K |
Scheduled
|
Sep 1
| ||
Form 4
| -1.09% | -1.20K |
$8.85 | -$10,622.40 | 108.94K |
Scheduled
|
Aug 1
| ||
Form 4
| -0.09% | -100.00 |
$8.00 | -$800.00 | 110.14K |
Scheduled
|
Jul 20
| ||
Form 4
| -0.63% | -700.00 |
$7.93 | -$5,550.30 | 110.24K |
Scheduled
|
Jul 1
| ||
Form 4
| -0.72% | -800.00 |
$7.90 | -$6,323.00 | 110.94K |
Scheduled
|
Jun 1
| ||
Form 4
| -0.36% | -400.00 |
$8.00 | -$3,200.00 | 111.74K |
Scheduled
|
May 16
| ||
Form 4
| -0.18% | -200.00 |
$7.00 | -$1,400.00 | 112.14K |
Scheduled
|
May 5
| ||
Form 4
| -0.62% | -700.00 |
$5.73 | -$4,010.00 | 112.34K |
Scheduled
|
May 2 - May 3
| ||
Form 4
| -0.44% | -500.00 |
$5.66 | -$2,830.00 | 113.04K |
Scheduled
|
Apr 1
| ||
Form 4
| -1.22% | -1.40K |
$7.04 | -$9,856.00 | 113.54K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Auspex Pharmaceuticals, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -144.44K |
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Design Therapeutics, Inc. (DSGN) Snapshot price: $2.33
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
∞
| 26.96K |
$3.70 | $99,738.48 | 26.96K |
Mar 22 - Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Poseida Therapeutics, Inc. (PSTX) Snapshot price: $3.385
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +50.00% | 19.65K |
—
|
—
| 58.95K |
Jun 17
| |||
Form 4
| +100.00% | 19.65K |
—
|
—
| 39.3K |
Jun 15
| |||
Form 4
|
∞
| 19.65K |
—
|
—
| 19.65K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||